Testing compliance to WHO guidelines for physical activity in Flanders insights from time-use diaries

在弗兰德斯地区测试对世界卫生组织身体活动指南的遵守情况,并从时间使用日记中获得启示

阅读:1

Abstract

BACKGROUND: Regular physical activity decreases the risk for numerous non-communicable diseases. The World Health Organization has suggested physical activity (PA) guidelines that, based on previous research, would provide health benefits to those who comply. The first guideline for health benefits suggests 150 min of moderate PA or equivalent per week. The guideline for additional health benefits suggests 300 min of PA or equivalent per week. The objective of this paper is to analyze to what extent these two WHO PA guidelines for adults are met in the Belgian region of Flanders. Furthermore, we are interested to see which groups are more or less likely to meet the PA guidelines. METHODS: Crosstables and logistic regressions are used on a sample of 3028 adults in the Belgian region of Flanders. All respondents filled in a 7-day time-diary in which they continuously recorded all their activities. RESULTS: Firstly, men are more likely than women to comply to both PA guidelines. Secondly, living with a partner increases the odds to comply to the guidelines. For men, this is the case for both guidelines, while for women, this only applies to the first guideline. Thirdly, women with a young child have lower odds to comply to the guidelines, while having a young child doesn't have an effect for men. CONCLUSION: Previous research on meeting PA guidelines in Flanders shows diverging results. Time-diary data allows researchers to strictly follow the WHO definition when operationalizing compliance to PA guidelines. There is a need for future research that combines time-diaries with a PA questionnaire and accelerometer data to gain more insights on the benefits and pitfalls of both methodologies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。